发明授权
US07754726B2 Benzamide derivatives as p-38 kinase inhibitors 失效
苯甲酰胺衍生物作为p-38激酶抑制剂

  • 专利标题: Benzamide derivatives as p-38 kinase inhibitors
  • 专利标题(中): 苯甲酰胺衍生物作为p-38激酶抑制剂
  • 申请号: US10565452
    申请日: 2004-07-23
  • 公开(公告)号: US07754726B2
    公开(公告)日: 2010-07-13
  • 发明人: Hengyuan LangJiong LanYunfeng Fang
  • 申请人: Hengyuan LangJiong LanYunfeng Fang
  • 申请人地址: CH Basel
  • 专利权人: Novartis AG
  • 当前专利权人: Novartis AG
  • 当前专利权人地址: CH Basel
  • 代理商 Sophie Binet Cross
  • 国际申请: PCT/US2004/023726 WO 20040723
  • 国际公布: WO2005/012241 WO 20050210
  • 主分类号: C07D239/42
  • IPC分类号: C07D239/42
Benzamide derivatives as p-38 kinase inhibitors
摘要:
Benzamide combounds of Formula I: and their compositions for modulating the activity of p38 kinases are provided, including p38α, and p38β kinase. Methods for treating, preventing or ameliorating one or more symptoms of a p38 kinase mediated disease or disorder such as inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, angiogenic disorders, infectious diseases, neurodegenerative diseases, and viral diseases are also provided.
公开/授权文献
信息查询
0/0